Alnylam Pharmaceuticals, Inc. (LON:0HD2)
London
· Delayed Price · Currency is GBP · Price in USD 319.59
+3.71 (1.17%)
At close: Jun 27, 2025
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 30.69 billion as of June 30, 2025. Its market cap has increased by 97.35% in one year.
Market Cap
30.69B
Enterprise Value
30.76B
Revenue
1.82B
Ranking
n/a
PE Ratio
n/a
Stock Price
319.59
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 63.23M to 30.69B, an increase of 48,446.67%. That is a compound annual growth rate of 34.07%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.54B |
| GSK plc | 56.88B |
| Haleon | 34.55B |
| Smith & Nephew | 9.70B |
| ConvaTec Group | 5.91B |
| Hikma Pharmaceuticals | 4.47B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.34B |